Tag: elizabeth_mcdonald
-
Penn Study Links GLP-1 Medications to Lower Breast Cancer Risk
A Penn Medicine study suggests GLP-1 medications may reduce breast cancer risk in women aged 45-80. Researchers are intrigued by the drugs' unexpected impact on various pathways associated with cancer development.
HealthScience & TechnologyBusinessMediaMedical ScienceArtificial IntelligenceEducationLegalSocial IssuesEnvironment GLP-1 medicationsBreast CancerPenn MedicineCancer ResearchWomen's HealthMedical StudyElizabeth McDonald